Dermo-Cosmetics Market Forecast Report 2023-2030 123 Pages Report - Benzinga
| 600186 Stock | 5.20 0.10 1.89% |
About 61% of Lotus Health's investor base is looking to short. The analysis of overall sentiment of trading Lotus Health Group stock suggests that many investors are alarmed at this time. The current market sentiment, together with Lotus Health's historical and current headlines, can help investors time the market. In addition, many technical investors use Lotus Health Group stock news signals to limit their universe of possible portfolio assets.
Lotus |
Dermo-Cosmetics Market Forecast Report 2023-2030 123 Pages Report Benzinga
Read at news.google.com
 |
Lotus Health Fundamental Analysis
We analyze Lotus Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lotus Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lotus Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Lotus Health is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Lotus Health Group Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lotus Health stock to make a market-neutral strategy. Peer analysis of Lotus Health could also be used in its relative valuation, which is a method of valuing Lotus Health by comparing valuation metrics with similar companies.
Peers
Lotus Health Related Equities
| 600340 | China Fortune | 10.07 | ||||
| 601995 | China International | 2.64 | ||||
| 001979 | China Merchants | 2.63 | ||||
| 600153 | Xiamen CD | 2.35 | ||||
| 600048 | Poly Real | 2.09 | ||||
| 000002 | China Vanke | 0.93 | ||||
| 600325 | Huafa Industrial | 0.60 | ||||
| 300750 | Contemporary Amperex | 0.36 | ||||
| 600519 | Kweichow Moutai | 0.05 |
Complementary Tools for Lotus Stock analysis
When running Lotus Health's price analysis, check to measure Lotus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Health is operating at the current time. Most of Lotus Health's value examination focuses on studying past and present price action to predict the probability of Lotus Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Health's price. Additionally, you may evaluate how the addition of Lotus Health to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |